Nathaniel Youndt

Nathaniel is the Vice President of Client Program Management for ReciBioPharm. Nathaniel brings experience in client management from both clinical and commercial CDMO spaces, holding roles of progressive client-facing responsibility at AMRI (now Curia), Thermo Fisher Scientific, and now within Recipharm’s advanced and emerging therapies business.

His leadership has encompassed sterile formulations and fill-finish, small molecules, and biologics drug substance and drug product, including mRNA, lipid nanoparticles, plasmid DNA, live biotherapeutics, and viral vectors.

Nathaniel holds a BA from Gordon College and an MBA from Indiana Wesleyan University.